UT StrokeNet

UT 中风网

• 批准号: 8895097
• 负责人: Jennifer Juhl Majersik
• 金额: $ 36.66万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-30 至 2016-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8895097
• 关键词: Acute; Address; Adult; Age; Agreement; Award; Bioinformatics; Biological Markers; Biometry; Blood Vessels; Caring; Cause of Death; Child; Childhood; Childhood stroke; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Clinical Services; Clinical Trials; Clinical and Translational Science Awards; Collaborations; Communities; Community Hospitals; Contracts; Coupling; Databases; Development; Development Plans; Discipline of Nursing; Effectiveness; Emergency Medicine; Enrollment; Extramural Activities; Faculty; Fellowship; Fostering; Functional Imaging; Funding; Genetic; Health; Health Sciences; Hospitals; Image; Image Analysis; Incidence; Infarction; Informed Consent; Inpatients; Institutional Review Boards; Insurance; K-Series Research Career Programs; Laboratories; Life; Magnetic Resonance Angiography; Medical; Medical center; Mentorship; Methodology; Methods; Minority; Molecular Medicine; Multicenter Trials; National Institute of Neurological Disorders and Stroke; Neurologist; Neurology; Neurosurgeon; Participant; Patient Care; Patients; Pediatric Hospitals; Platelet aggregation; Population Heterogeneity; Positioning Attribute; Prevention; Principal Investigator; Recovery; Recurrence; Research; Research Design; Research Infrastructure; Research Personnel; Research Training; Resources; Sampling; Science; Services; Site; Stroke; Stroke prevention; Thrombolytic Therapy; Thrombosis; Time; Training; Translational Research; United States National Institutes of Health; Universities; University Hospitals; Utah; Woman; base; career development; clinical investigation; cost; disability; effectiveness trial; experience; genetic epidemiology; improved; innovation; interest; malformation; multidisciplinary; neuroimaging; outreach; point of care; population based; programs; protocol development; racial and ethnic; radiologist; research facility; skills; social; socioeconomics; statistics; success; tool; translational neuroscience

DESCRIPTION (provided by applicant): The University of Utah Health Sciences Center (UUHC) is ideally positioned to serve as a Regional Coordinating Center for the Network. "Utah StrokeNet" will serve the Intermountain West, a 5-state region encompassing 10% of the U.S. landmass. UUHC is the only regional academic medical facility and Comprehensive Stroke Center. UT StrokeNet will include Primary Children's Medical Center, the 4-state/15- spoke Telestroke Network, and Utah Regional NeuroNEXT network which includes Intermountain Medical Center (IMC), and numerous community hospitals. UT StrokeNet brings unique strengths to the Network: 1. Wide catchment: Via the collaboration between UUHC and IHC, almost every resident of any age with any insurance plan living in the Intermountain West will have access to the UT StrokeNet. The Utah Telestroke Network reaches remote corners in four states. 2. Strong support from the CCTS including clinical research space and nursing support, community engagement, biostatistics and study design support. 3. Neurology Clinical Trials Office, a department-supported resource for NIH-sponsored trials, which provides comprehensive support including contracting, IRB submission, protocol development, and coordination. 4. Availability of Adult and Pediatric Hospitals with specialized multidisciplinary stroke teams. UUHC benefits from University Hospital and PCMC each of which has strong stroke services with a demonstrated track record of successful participation in NIH-sponsored clinical trials 5. Innovative recruitment strategies, including social media-based methods and an institutional drive to utilize the established Telestroke Network 6. Career Development and Mentorship Resources: MS in Clinical Investigation, the KL2 program, and the Molecular Medicine Program. The resources have demonstrated effectiveness, with a career development award success rate of >90%. 7. Translational Research: UT StrokeNet will bring to the Network expertise in vascular malformations, thrombosis and platelet aggregation, neurovascular coupling and peri-infarct depolarization, stroke genetics, population-based genetic epidemiology, and functional imaging and imaging analysis.

描述（由申请人提供）：犹他大学健康科学中心（uhc）的理想定位是作为该网络的区域协调中心。“犹他StrokeNet”将服务于山间西部，这是一个由5个州组成的地区，占美国陆地面积的10%。uhc是唯一的区域性学术医疗机构和综合中风中心。UT StrokeNet将包括初级儿童医疗中心、4州/15条中风网络和犹他地区神经网络，其中包括山间医疗中心（IMC）和众多社区医院。UT StrokeNet为网络带来独特的优势：广泛的集水区：通过uhc和IHC之间的合作，几乎所有居住在山间西部的任何年龄和任何保险计划的居民都可以使用UT StrokeNet。犹他电讯网络覆盖了四个州的偏远角落。2. CCTS的大力支持，包括临床研究空间和护理支持、社区参与、生物统计和研究设计支持。3. 神经病学临床试验办公室，为nih赞助的试验提供部门支持资源，提供包括签约、IRB提交、方案制定和协调在内的全面支持。4. 拥有多学科中风专业团队的成人和儿科医院的可用性。uhc受益于大学医院和PCMC，这两个医院都有强大的中风服务，并有成功参与美国国立卫生研究院赞助的临床试验的记录5。创新招聘策略，包括基于社交媒体的方法和利用已建立的telest卒中网络的制度性驱动。职业发展和指导资源：临床研究硕士，KL2项目和分子医学项目。这些资源已显示出成效，职业发展奖励的成功率达50%至90%。7. 转化研究：UT StrokeNet将为网络带来血管畸形、血栓形成和血小板聚集、神经血管耦合和梗死周围去极化、中风遗传学、基于人群的遗传流行病学以及功能成像和成像分析方面的专业知识。